Translational PET Imaging of Spinal Cord Injury with the Serotonin Transporter Tracer [11C]AFM

Mol Imaging Biol. 2022 Aug;24(4):560-569. doi: 10.1007/s11307-021-01698-7. Epub 2022 Jan 12.

Abstract

Purpose: The descending raphespinal serotonin (5-HT) system contributes to neural activities required for locomotion. The presynaptic serotonin transporter (SERT) is a marker of 5-HT innervation. In this study, we explored the use of PET imaging with the SERT radioligand [11C]AFM as a biomarker of 5-HT axon damage after spinal cord injury (SCI) in a rodent model and its translation to imaging SCI in humans.

Procedures: PET imaging with [11C]AFM was performed in healthy rats under baseline and citalopram blocking conditions and a mid-thoracic transection rat model of SCI. The lumbar-to-cervical activity (L/C) ratio was calculated for the healthy and SCI animals to assess SERT binding decrease after SCI. Finally, translation of [11C]AFM PET was attempted to explore its potential to image SCI in humans.

Results: Intense uptake in the brain and intact spinal cord was observed at 30-60 min post-injection of [11C]AFM in healthy rats. About 65% of [11C]AFM uptake in the spinal cord was blocked by citalopram. In the SCI rat model, the cervical uptake of [11C]AFM was similar to that in healthy rats, but the lumbar uptake was dramatically reduced, resulting in about half the L/C ratio in SCI rats compared to healthy rats. In contrast, [11C]AFM uptake in the human spinal cord showed no obvious decrease after treatment with citalopram. In the human subjects with SCI, decreases in [11C]AFM uptake were also not obvious in the section of spinal cord caudal to the injury point.

Conclusion: [11C]AFM PET imaging of SERT provides a useful preclinical method to non-invasively visualize the rodent spinal cord and detect SERT changes in SCI rodent models. However, there appears to be little detectable specific binding signal for [11C]AFM in the human spinal cord. An SERT tracer with higher affinity and lower non-specific binding signal is needed to image the spinal cord in humans and to assess the axonal status in SCI patients.

Keywords: PET imaging; Serotonin transporter; Spinal cord injury; [11C]AFM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Citalopram
  • Humans
  • Indicators and Reagents
  • Positron-Emission Tomography / methods
  • Rats
  • Serotonin / metabolism
  • Serotonin Plasma Membrane Transport Proteins* / metabolism
  • Spinal Cord / diagnostic imaging
  • Spinal Cord Injuries* / diagnostic imaging
  • Spinal Cord Injuries* / metabolism
  • Tissue Distribution

Substances

  • Indicators and Reagents
  • Serotonin Plasma Membrane Transport Proteins
  • Citalopram
  • Serotonin